Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 23.
doi: 10.1007/s10787-025-01811-0. Online ahead of print.

Acteoside as a multifunctional natural glycoside: therapeutic potential across various diseases

Affiliations
Review

Acteoside as a multifunctional natural glycoside: therapeutic potential across various diseases

Reham A Mohammed et al. Inflammopharmacology. .

Abstract

Phenylethanoid glycosides are naturally occurring water-soluble molecules with remarkable biological characteristics that are abundant throughout the plant world. Acteoside (AC) is a phenylethanoid glycoside that was first discovered in mullein, but is also found in various other plant species. It has four moieties: caffeic acid, glucose, rhamnose, and phenylethyl alcohol. AC is an important bioactive natural compound isolated from many plant species. Extracts from different plant species, including Barleria prionitis, B. lupulina, Rhinacanthus nasutus, Orthosiphon aristatus, and Nicoteba betonica, have high quantities of AC. AC is hydrophilic in nature, and it has several bioactivities such as anti-inflammatory, antibacterial, antiviral, antioxidant, antidiabetic, neuroprotective, cardioprotective, anticancer, and wound-healing properties. In this review, we discuss its prominent pharmacological properties. The findings provide valuable insights for future research on AC which exhibit promising anti-inflammatory activities.

Keywords: Acetoside; Acteoside; Anti-inflammatory; Kusaginin; Phenylethanoid glycoside; Verbascoside.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests. Animal ethics declaration: Not applicable.

Similar articles

Cited by

References

    1. Abdallah HM, El-Halawany AM, Sirwi A, El-Araby AM, Mohamed GA, Ibrahim SR, Koshak AE, Asfour HZ, Awan ZA, Elfaky MA (2021) Repurposing of some natural product isolates as SARS-COV-2 main protease inhibitors via in vitro cell free and cell-based antiviral assessments and molecular modeling approaches. Pharmaceuticals 14(3):213 - PubMed - PMC - DOI
    1. Ahmad M, Rizwani GH, Aftab K, Ahmad VU, Gilani AH, Ahmad SP (1995) Acteoside: a new antihypertensive drug. Phytother Res 9(7):525–527 - DOI
    1. Ahmed SA, Saikia K, Basumatary D, Gurumayum S, Swargiary D, Borah JC (2025) Verbascoside as a potential SGLT2 inhibitor in diabetic nephropathy: targeting AMPK activation to suppress NOX4/NF-κB signaling and attenuate inflammation and fibrosis. Int Immunopharmacol 158:114825 - PubMed - DOI
    1. Aimaiti M, Wumaier A, Aisa Y, Zhang Y, Xirepu X, Aibaidula Y, Lei X, Chen Q, Feng X, Mi N (2021) Acteoside exerts neuroprotection effects in the model of Parkinson’s disease via inducing autophagy: network pharmacology and experimental study. Eur J Pharmacol 903:174136 - PubMed - DOI
    1. Akgun-Cagliyan G, Cort-Donmez A, Kilic-Toprak E, Altintas F (2022) Verbascoside potentiates the effect of tyrosine kinase inhibitors on the induction of apoptosis and oxidative stress via the Abl-mediated MAPK signalling pathway in chronic myeloid leukaemia. Exp Ther Med 24(2):514 - PubMed - PMC - DOI